BOLETIN INFORMATIVO Nº 6 – Septiembre 2022
Estimados colegas del Programa Nacional de Control de Calidad en Bacteriología (PCC-NAC):
En el presente BOLETÍN INFORMATIVO Nº 6 enviamos:
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399: 629–55. Published Online January 20, 2022 https://doi.org/10.1016/S0140-6736(21)02724-0.
- Real-Time Optimization of Pharmacodynamic Target Attainment at Infection Site during Treatment of Post-Neurosurgical Ventriculitis Caused by Carbapenem- Resistant Gram Negatives with Ceftazidime–Avibactam-Based Regimens: A Report of Two Cases. Gattiycol. Microorganisms 2022, 10, 154.https://doi.org/10.3390/microorganisms10010154
- Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing. Gaibani y col. Antibiotics 2022, 11, 628.https://doi.org/10.3390/antibiotics11050628
- Successful Treatment of Acinetobacter Baumannii Infection in Burn Child with Avibactam/Sulbactam: A Case Report. Ghunaim y col.Ann Clin Med Case Rep. 2022; V9(8): 1-4
Cariños para todos!
Alejandra y Paola
Servicio Antimicrobianos
LNR/LRR en Resistencia a los Antimicrobianos
INEI-ANLIS. “Dr. Carlos G Malbrán”
